Invesco Dynamic Pharmaceuticals ETF (PJP)
|Ex-Dividend Date||Sep 20, 2021|
|Day's Range||78.10 - 78.76|
|Inception Date||Jun 23, 2005|
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Top 10 Holdings56.22% of assets
|Johnson & Johnson||JNJ||5.80%|
|Sep 20, 2021||$0.175||Sep 30, 2021|
|Jun 21, 2021||$0.14784||Jun 30, 2021|
|Mar 22, 2021||$0.15259||Mar 31, 2021|
|Dec 21, 2020||$0.13052||Dec 31, 2020|
|Sep 21, 2020||$0.11658||Sep 30, 2020|
|Jun 22, 2020||$0.15557||Jun 30, 2020|
Sector ETF report for PJP
The Invesco Dynamic Pharmaceuticals ETF (NYSEArca: PJP) is off 3.66% month-to-date, and the source of that lethargy is easy to spot: The drug price reform debate is once again gaining momentum, promptin...
The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs. The Invesco Dynamic Pharmaceuticals ETF (NYSEArca:...
Robust results led to solid trading in pharma ETFs in a month.
Despite robust results, pharma ETFs have been trending downward in a month.